Clinical trial / 2006
A low-fat vegan diet led to greater improvements in glycemic control and cardiovascular risk factors than an ADA diet in people with type 2 diabetes.
Ninety-nine individuals with type 2 diabetes were randomly assigned to a low-fat vegan diet (n = 49) or an ADA guidelines diet (n = 50) for 22 weeks. Excluding participants who changed medications, HbA1c fell 1.23 points in the vegan group compared with 0.38 points in the ADA group (P = 0.01). Body weight decreased 6.5 kg in the vegan group compared with 3.1 kg in the ADA group (P < 0.001). Among those not changing lipid-lowering medications, LDL cholesterol fell 21.2% in the vegan group and 10.7% in the ADA group (P = 0.02), and urinary albumin reductions were also greater in the vegan group (15.9 mg/24 h vs. 10.9 mg/24 h, P = 0.013).
- Study type
- Randomized clinical trial
- Who was studied
- 99 individuals with type 2 diabetes
- What was measured
- Glycemic control (HbA1c), body weight, lipid levels (LDL cholesterol), and urinary albumin
THE PAPER
A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes.
Barnard ND, Cohen J, Jenkins DJ, Turner-McGrievy G, Gloede L, Jaster B, Seidl K, Green AA, Talpers S. Diabetes Care, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.